Therapeutic and prognostic values of ferroptosis signature in glioblastoma
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Reza Nedaeinia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical…. Hauptthemen laut MEDLINE: Ferroptosis, Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 190 Literaturangaben. Gefördert von: Isfahan University of Medical Sciences.
Abstract (Originalsprache)
Ferroptosis is a regulated cell death process that results in decreased tumor growth and aggressiveness when targeted in various cancer cells. Studying the impact of ferroptosis in glioblastoma (GBM) will provide important knowledge about tumor biology and potential treatment strategies. The high metabolic activity resulting in ROS production, iron content and active lipid metabolism of glioblastoma cells make them particularly susceptible to ferroptosis. Single-cell RNA sequencing reveals the molecular signature of GBM and its tumor microenvironment, introducing ferroptosis-related biomarkers pathways and drug resistance mechanisms to enhance treatment outcomes for GBM patients. The relationship between ferroptosis and the immune landscape in GBM is complex and can have either positive or negative effects. These effects can be identified through single-cell RNA sequencing to develop targeted chemo-, radio- and immuno- therapies against glioma stem cells and tumor-supportive immune cells. Additionally, the implication of oncolytic virotherapy in combination with ferroptosis induction can lead to improved treatment of GBM in a clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
- Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Genetics and Molecular Biology…
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
- Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Förderung
- Isfahan University of Medical Sciences
Zitieren
APA
Nedaeinia, R., Dianat-Moghadam, H., Movahednasab, M., Khosroabadi, Z., Keshavarz, M., Amoozgar, Z., & Salehi, R. (2025). Therapeutic and prognostic values of ferroptosis signature in glioblastoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114597
Vancouver
Nedaeinia R, Dianat-Moghadam H, Movahednasab M, Khosroabadi Z, Keshavarz M, Amoozgar Z, et al. Therapeutic and prognostic values of ferroptosis signature in glioblastoma. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114597
BibTeX
@article{Nedaeinia2025,
author = {Nedaeinia, Reza and Dianat-Moghadam, Hassan and Movahednasab, Maedeh and Khosroabadi, Zahra and Keshavarz, Mohsen and Amoozgar, Zohreh and Salehi, Rasoul},
title = {Therapeutic and prognostic values of ferroptosis signature in glioblastoma},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114597}
}
EUVIMED